Medtronic platform acquired
September 2, 2024
Source: drugdu
97
Recently, PaceMate, a provider of cardiac remote monitoring solutions, announced that it has successfully acquired Medtronic's localized cardiac workflow solution Paceart Optima. However, the financial details of the transaction have not yet been disclosed to the public.
As an innovator of cardiac health data management solutions, PaceMate has gained wide recognition in recent years for its remote monitoring technology. The integration of the Paceart Optima system is expected to add nearly 1,000 new clinic partners worldwide.
For Medtronic, this divestiture is in line with its overall strategy of focusing resources on core innovation and therapeutic advances. PaceMate has further consolidated its market leadership and expanded its global influence by increasing the depth and breadth of its services. Next, Medtronic's cardiac rhythm management (CRM) business will work closely with PaceMate to ensure a smooth transition.
https://mp.weixin.qq.com/s/GQmozVWWkMxQcAebSM4T-Q
By editor
Copyright©2024 Ddu. All rights reserved.
Read more on
- Over 5.7 billion! China’s dual antibody ADC goes global+1 November 21, 2024
- Is Jingtai Technology once again breaking through the “first AI pharmaceutical stock” halo and shedding? November 21, 2024
- Yangqi Medical Chip completes tens of millions of yuan in Pre-A round financing November 21, 2024
- Endovascular stent approved through priority green channel November 21, 2024
- Well-known products of foreign companies such as AZ, Eli Lilly, and Sanofi were disqualified November 21, 2024
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
